vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and RXO, Inc. (RXO). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $1.5B, roughly 2.0× RXO, Inc.). Quest Diagnostics runs the higher net margin — 9.7% vs -3.1%, a 12.8% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs -11.9%). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 9.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

DGX vs RXO — Head-to-Head

Bigger by revenue
DGX
DGX
2.0× larger
DGX
$2.9B
$1.5B
RXO
Growing faster (revenue YoY)
DGX
DGX
+21.0% gap
DGX
9.2%
-11.9%
RXO
Higher net margin
DGX
DGX
12.8% more per $
DGX
9.7%
-3.1%
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
9.9%
DGX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGX
DGX
RXO
RXO
Revenue
$2.9B
$1.5B
Net Profit
$281.0M
$-46.0M
Gross Margin
Operating Margin
15.4%
-2.9%
Net Margin
9.7%
-3.1%
Revenue YoY
9.2%
-11.9%
Net Profit YoY
12.0%
-84.0%
EPS (diluted)
$2.24
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
RXO
RXO
Q1 26
$2.9B
Q4 25
$2.8B
$1.5B
Q3 25
$2.8B
$1.4B
Q2 25
$2.8B
$1.4B
Q1 25
$2.7B
$1.4B
Q4 24
$2.6B
$1.7B
Q3 24
$2.5B
$1.0B
Q2 24
$2.4B
$930.0M
Net Profit
DGX
DGX
RXO
RXO
Q1 26
$281.0M
Q4 25
$245.0M
$-46.0M
Q3 25
$245.0M
$-14.0M
Q2 25
$282.0M
$-9.0M
Q1 25
$220.0M
$-31.0M
Q4 24
$222.0M
$-25.0M
Q3 24
$226.0M
$-243.0M
Q2 24
$229.0M
$-7.0M
Gross Margin
DGX
DGX
RXO
RXO
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
DGX
DGX
RXO
RXO
Q1 26
15.4%
Q4 25
13.8%
-2.9%
Q3 25
13.7%
-0.5%
Q2 25
15.9%
Q1 25
13.0%
-2.1%
Q4 24
13.8%
-1.4%
Q3 24
13.3%
-1.9%
Q2 24
14.8%
Net Margin
DGX
DGX
RXO
RXO
Q1 26
9.7%
Q4 25
8.7%
-3.1%
Q3 25
8.7%
-1.0%
Q2 25
10.2%
-0.6%
Q1 25
8.3%
-2.2%
Q4 24
8.5%
-1.5%
Q3 24
9.1%
-23.4%
Q2 24
9.6%
-0.8%
EPS (diluted)
DGX
DGX
RXO
RXO
Q1 26
$2.24
Q4 25
$2.18
$-0.28
Q3 25
$2.16
$-0.08
Q2 25
$2.47
$-0.05
Q1 25
$1.94
$-0.18
Q4 24
$1.95
$-0.17
Q3 24
$1.99
$-1.81
Q2 24
$2.03
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$393.0M
$17.0M
Total DebtLower is stronger
$5.7B
$387.0M
Stockholders' EquityBook value
$7.7B
$1.5B
Total Assets
$16.7B
$3.3B
Debt / EquityLower = less leverage
0.74×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
RXO
RXO
Q1 26
$393.0M
Q4 25
$420.0M
$17.0M
Q3 25
$432.0M
$25.0M
Q2 25
$319.0M
$18.0M
Q1 25
$188.0M
$16.0M
Q4 24
$549.0M
$35.0M
Q3 24
$764.0M
$55.0M
Q2 24
$271.0M
$7.0M
Total Debt
DGX
DGX
RXO
RXO
Q1 26
$5.7B
Q4 25
$5.2B
$387.0M
Q3 25
$5.2B
$387.0M
Q2 25
$5.2B
$387.0M
Q1 25
$5.9B
$387.0M
Q4 24
$5.6B
$351.0M
Q3 24
$5.6B
$352.0M
Q2 24
$3.8B
$370.0M
Stockholders' Equity
DGX
DGX
RXO
RXO
Q1 26
$7.7B
Q4 25
$7.2B
$1.5B
Q3 25
$7.3B
$1.6B
Q2 25
$7.2B
$1.6B
Q1 25
$6.9B
$1.6B
Q4 24
$6.8B
$1.6B
Q3 24
$6.8B
$1.7B
Q2 24
$6.6B
$579.0M
Total Assets
DGX
DGX
RXO
RXO
Q1 26
$16.7B
Q4 25
$16.2B
$3.3B
Q3 25
$16.2B
$3.2B
Q2 25
$16.0B
$3.2B
Q1 25
$15.8B
$3.3B
Q4 24
$16.2B
$3.4B
Q3 24
$16.1B
$3.4B
Q2 24
$13.9B
$1.8B
Debt / Equity
DGX
DGX
RXO
RXO
Q1 26
0.74×
Q4 25
0.72×
0.25×
Q3 25
0.71×
0.24×
Q2 25
0.72×
0.24×
Q1 25
0.85×
0.24×
Q4 24
0.83×
0.22×
Q3 24
0.83×
0.21×
Q2 24
0.58×
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
RXO
RXO
Operating Cash FlowLast quarter
$278.0M
$7.0M
Free Cash FlowOCF − Capex
$-9.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
3.9%
1.1%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
RXO
RXO
Q1 26
$278.0M
Q4 25
$465.0M
$7.0M
Q3 25
$563.0M
$23.0M
Q2 25
$544.0M
$23.0M
Q1 25
$314.0M
$-2.0M
Q4 24
$464.0M
$-7.0M
Q3 24
$356.0M
$-7.0M
Q2 24
$360.0M
$-5.0M
Free Cash Flow
DGX
DGX
RXO
RXO
Q1 26
Q4 25
$307.0M
$-9.0M
Q3 25
$419.0M
$9.0M
Q2 25
$436.0M
$9.0M
Q1 25
$197.0M
$-17.0M
Q4 24
$341.0M
$-19.0M
Q3 24
$250.0M
$-18.0M
Q2 24
$268.0M
$-16.0M
FCF Margin
DGX
DGX
RXO
RXO
Q1 26
Q4 25
10.9%
-0.6%
Q3 25
14.9%
0.6%
Q2 25
15.8%
0.6%
Q1 25
7.4%
-1.2%
Q4 24
13.0%
-1.1%
Q3 24
10.0%
-1.7%
Q2 24
11.2%
-1.7%
Capex Intensity
DGX
DGX
RXO
RXO
Q1 26
3.9%
Q4 25
5.6%
1.1%
Q3 25
5.1%
1.0%
Q2 25
3.9%
1.0%
Q1 25
4.4%
1.0%
Q4 24
4.7%
0.7%
Q3 24
4.3%
1.1%
Q2 24
3.8%
1.2%
Cash Conversion
DGX
DGX
RXO
RXO
Q1 26
0.99×
Q4 25
1.90×
Q3 25
2.30×
Q2 25
1.93×
Q1 25
1.43×
Q4 24
2.09×
Q3 24
1.58×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGX
DGX

Segment breakdown not available.

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons